|
Save the date!
Our virtual N2B-patch Symposium will take place on 17 June 2021.
Stay tuned - more information and registration will follow soon!
|
10.05.2021
News
|
|
Save the date!
Our virtual N2B-patch Symposium will take place on 17 June 2021.
Stay tuned - more information and registration will follow soon!
|
The COVID-19 pandemic stopped and delayed drastically important project work planned for spring/ summer 2020. The delay forced us to ask for an extension of our project by 6 months. We are happy, that our amendment request was finally accepted by the European Commission and that the N2B-patch Consortium can continue its work until June 2021.
|
 Prof. Andrew Chan - University of Bern |
The 8th Joint ACTRIMS/ECTRIMS Meeting “MS Virtual 2020” will take place from 11 to 13 September 2020. Our project partners EMSP and Prof. Andrew Chan from University of Bern will join this year again. Take a look back with us and watch the interview that we recorded during ACTRIMS/ECTRIMS Meeting 2019 in Stockholm. Andrew Chan is explaining why it is so important for us to get in touch with relevant stakeholders at conferences like the ACTRIMS/ECTRIMs joint event. Furthermore, he is describing his two different tasks in the project, as a clinician as well as a researcher.
Many thanks to Andrew Chan, EMSP and LGI for giving, organising and recording this great presentation!
You can watch the video in our download section or just visit our N2B-patch youtube channel.
Stay tuned and subscribe to our N2B-patch video channel!
|
|
We just published Part II of our Greece interviews.
Listen to our 3 project partners Martino Calamai (LENS), Matt Burton (Jen) and Jenny Ullrich (Fraunhofer) answering the question: "What could be the benefit of N2B-patch for society?"
Many thanks again to our project partner LGI who recorded these interviews and prepared the final video.
You can watch the video in our download section or just visit our N2B-patch youtube channel.
Stay tuned and subscribe to our N2B-patch youtube channel!
|
 Prof. Mavoungou (HBC) wearing the face mask produced by Beiter for lab work. |
Our project partner Beiter is producing face masks to support a sustainable personal protection against the Corona virus.
The SME placed in southern Germany is using their expertise in injection molding to contribute to the current challenging situation. All parts of the masks are produced locally and are from high quality. The masks can easily be assembled, and adapted to an individual head size. The plexiglass panel can be removed and cleaned separately. It will be delivered with a forehead pad for better wearing comfort.
We are pleased about the great inventive talent of our project partner and wish everyone continued good health.
Please visit their website for more information: http://beiter.de/
|
 Prof. Dr. Chrystelle Mavoungou (HBC) and Rolf Pfäffle (Beiter) |
The regional television channel regio TV produced a short report on N2B-patch together with our project partners HBC and Beiter.
It was published on March 10th and can be reviewed on their website (in German only):
|
|
We just published the next N2B-patch video. The interview format has changed and project partner LGI recorded several partners during our Month-30 Consortium meeting in Greece answering the question: Why is N2B-patch important to you?
Have look what Costas Kiparissides (CERTH), Katharina Zimmermann (HBC), Matthew Burton (Jenson), Nora Kriauzaite (EMSP) and Lenka Kovarova (Contipro) said.
You can watch the video in our download section or just visit our N2B-patch youtube channel.
Stay tuned and subscribe to our N2B-patch youtube channel! Part II of our Greece interviews will be published soon.
|
|
A survey gathered the perspective of over 300 people living with MS across Europe to better understand their expectations from this project. Their questions as well as other questions that might be important for the MS community are summarised in the section For Patients. The N2B-patch scientific team has provided the anwers.
EMSP recently published an article on this called "13 things people with MS expect from N2B-patch".
If you have additional questions please do not hesitate to contact the European Multiple Sclerosis Platform (EMSP) at http://www.emsp.org/contact/.
|
 Dr. Nazende Günday-Türeli - MJR PharmJet |
We recently published the next N2B-patch partner interview.
Dr. Nazende Günday-Türeli was interviewed during the Month-24 Meeting that took place at their facilities. Thanks a lot for hosting us!
Nazende explains the role of MJR PharjmJet within our project and provides some information about the gel that we are developing and why this is unique.
The last question concerns their equipment, she describes what the Consortium was able to see during the site visit right after the meeting.
You can watch the video in our download section or just visit our N2B-patch youtube channel.
Stay tuned and subscribe to our N2B-patch youtube channel! Next interviews were already recorded - in a new format - and will be published soon.
|
Dr. Carmen Gruber-Traub, the N2B-patch Project Coordinator, is answering questions about her experiences in European research projects and the role of Fraunhofer IGB in N2B-patch. Furthermore she is explaining the difference of the N2B-patch technology concept compared to current MS treatment methods; if N2B-patch can be used for other drugs and what main challenges we are facing within the N2B-patch platform development.
This is one of two videos produced at our Month-24 Consortium Meeting at MJR PharmJet.
You can watch the video in our download section or just visit our N2B-patch youtube channel.
Stay tuned and subscribe to our N2B-patch youtube channel!
|
| Share N2B-patch |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 721098
